Change in Tongue Strength and Fatigue After Upper Airway Stimulation Therapy
1 other identifier
observational
103
1 country
1
Brief Summary
Upper airway stimulation (UAS) is an effective surgical alternative for patients with obstructive sleep apnea (OSA) who fail continuous positive airway pressure (CPAP) therapy. This stimulation could lead to alterations in tongue strength and fatigability which could alter treatment outcome. The aim of the study is to investigate if UAS alters tongue strength and fatigability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 16, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 16, 2018
CompletedFirst Submitted
Initial submission to the registry
May 26, 2019
CompletedFirst Posted
Study publicly available on registry
June 10, 2019
CompletedJune 10, 2019
June 1, 2019
9 months
May 26, 2019
June 6, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Tongue protrusion strength
Tongue protrusion strength (peak pressure in kPa)
Up to 60 months after implanation
Tongue fatigability
Time to task failure during 50% of peak pressure contraction in seconds
Up to 60 months after implanation
Study Arms (3)
Upper airway stimulation group
OSA group with conservative / no treatment
Test group without OSA
Eligibility Criteria
The study population consists of three groups: the first group comprises of patients that have been implanted with selective hypoglossal nerve stimulation system (Inspire II Upper Airway Stimulation System, Inspire Medical Systems, Maple Grove, USA). The second group consists of confirmed OSA patients either being treated conservatively or without treatment. The test group consists of participants with no medical history for OSA and Epworth Sleepiness Scale (ESS) below 11.
You may qualify if:
- years old or older
- upper airway stimulation group: Upper airway stimulation system implanted at least 4 weeks ago
- OSA group: OSA confirmed by 18-channel inpatient overnight polysomnography (PSG)
- test group: No medical history for OSA and Epworth Sleepiness Scale (ESS) below 11
You may not qualify if:
- history of a neuromuscular disorder
- previous tongue surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Ear Nose Throat
Munich, Bavaria, 81675, Germany
Related Publications (1)
Wirth M, Unterhuber D, von Meyer F, Hofauer B, Ott A, Edenharter G, Eckert DJ, Heiser C. Hypoglossal nerve stimulation therapy does not alter tongue protrusion strength and fatigability in obstructive sleep apnea. J Clin Sleep Med. 2020 Feb 15;16(2):285-292. doi: 10.5664/jcsm.8184. Epub 2020 Jan 13.
PMID: 31992396DERIVED
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 26, 2019
First Posted
June 10, 2019
Study Start
March 1, 2018
Primary Completion
November 16, 2018
Study Completion
November 16, 2018
Last Updated
June 10, 2019
Record last verified: 2019-06